Report Detail

Pharma & Healthcare Global Antiparasitic Drugs for Pets Market Research Report 2022

  • RnM4457557
  • |
  • 22 June, 2022
  • |
  • Global
  • |
  • 91 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Industry Insights
Due to the COVID-19 pandemic, the global Antiparasitic Drugs for Pets market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Antiparasitic Drugs for Pets market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Antiparasitic Drugs for Pets landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

In Vitro Deworming Medicine accounting for % of the Antiparasitic Drugs for Pets global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cats segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Antiparasitic Drugs for Pets include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Ceva, Vetoquinol, Ouro Fino Saude and JINDUN, etc. In terms of revenue, the global 3 largest players have a % market share of Antiparasitic Drugs for Pets in 2021.

This report focuses on Antiparasitic Drugs for Pets volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Antiparasitic Drugs for Pets market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Antiparasitic Drugs for Pets market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

In Vitro Deworming Medicine

In Vivo Deworming Medicine

Segment by Application

Cats

Doges

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Zoetis

Boehringer Ingelheim

Merck

Elanco

Virbac

Ceva

Vetoquinol

Ouro Fino Saude

JINDUN

Zhongbolvya

CAHIC

Frequently Asked Questions

Which product segment grabbed the largest share in the Antiparasitic Drugs for Pets market?

How is the competitive scenario of the Antiparasitic Drugs for Pets market?

Which are the key factors aiding the Antiparasitic Drugs for Pets market growth?

Which are the prominent players in the Antiparasitic Drugs for Pets market?

Which region holds the maximum share in the Antiparasitic Drugs for Pets market?

What will be the CAGR of the Antiparasitic Drugs for Pets market during the forecast period?

Which application segment emerged as the leading segment in the Antiparasitic Drugs for Pets market?

What key trends are likely to emerge in the Antiparasitic Drugs for Pets market in the coming years?

What will be the Antiparasitic Drugs for Pets market size by 2028?

Which company held the largest share in the Antiparasitic Drugs for Pets market?


1 Antiparasitic Drugs for Pets Market Overview

  • 1.1 Product Overview and Scope of Antiparasitic Drugs for Pets
  • 1.2 Antiparasitic Drugs for Pets Segment by Type
  • 1.2.1 Global Antiparasitic Drugs for Pets Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 In Vitro Deworming Medicine
  • 1.2.3 In Vivo Deworming Medicine
  • 1.3 Antiparasitic Drugs for Pets Segment by Application
  • 1.3.1 Global Antiparasitic Drugs for Pets Sales Comparison by Application: (2022-2028)
  • 1.3.2 Cats
  • 1.3.3 Doges
  • 1.3.4 Others
  • 1.4 Global Antiparasitic Drugs for Pets Market Size Estimates and Forecasts
  • 1.4.1 Global Antiparasitic Drugs for Pets Revenue 2017-2028
  • 1.4.2 Global Antiparasitic Drugs for Pets Sales 2017-2028
  • 1.4.3 Antiparasitic Drugs for Pets Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 Antiparasitic Drugs for Pets Market Competition by Manufacturers

    • 2.1 Global Antiparasitic Drugs for Pets Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Antiparasitic Drugs for Pets Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Antiparasitic Drugs for Pets Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Antiparasitic Drugs for Pets Manufacturing Sites, Area Served, Product Type
    • 2.5 Antiparasitic Drugs for Pets Market Competitive Situation and Trends
    • 2.5.1 Antiparasitic Drugs for Pets Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Antiparasitic Drugs for Pets Players Market Share by Revenue
  • 2.5.3 Global Antiparasitic Drugs for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 Antiparasitic Drugs for Pets Retrospective Market Scenario by Region

    • 3.1 Global Antiparasitic Drugs for Pets Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Antiparasitic Drugs for Pets Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Antiparasitic Drugs for Pets Market Facts & Figures by Country
    • 3.3.1 North America Antiparasitic Drugs for Pets Sales by Country
  • 3.3.2 North America Antiparasitic Drugs for Pets Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe Antiparasitic Drugs for Pets Market Facts & Figures by Country
  • 3.4.1 Europe Antiparasitic Drugs for Pets Sales by Country
  • 3.4.2 Europe Antiparasitic Drugs for Pets Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific Antiparasitic Drugs for Pets Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Antiparasitic Drugs for Pets Sales by Region
  • 3.5.2 Asia Pacific Antiparasitic Drugs for Pets Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America Antiparasitic Drugs for Pets Market Facts & Figures by Country
  • 3.6.1 Latin America Antiparasitic Drugs for Pets Sales by Country
  • 3.6.2 Latin America Antiparasitic Drugs for Pets Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
  • 3.7 Middle East and Africa Antiparasitic Drugs for Pets Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Antiparasitic Drugs for Pets Sales by Country
  • 3.7.2 Middle East and Africa Antiparasitic Drugs for Pets Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global Antiparasitic Drugs for Pets Historic Market Analysis by Type

    • 4.1 Global Antiparasitic Drugs for Pets Sales Market Share by Type (2017-2022)
    • 4.2 Global Antiparasitic Drugs for Pets Revenue Market Share by Type (2017-2022)
    • 4.3 Global Antiparasitic Drugs for Pets Price by Type (2017-2022)

    5 Global Antiparasitic Drugs for Pets Historic Market Analysis by Application

    • 5.1 Global Antiparasitic Drugs for Pets Sales Market Share by Application (2017-2022)
    • 5.2 Global Antiparasitic Drugs for Pets Revenue Market Share by Application (2017-2022)
    • 5.3 Global Antiparasitic Drugs for Pets Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Zoetis
    • 6.1.1 Zoetis Corporation Information
  • 6.1.2 Zoetis Description and Business Overview
  • 6.1.3 Zoetis Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 Zoetis Antiparasitic Drugs for Pets Product Portfolio
  • 6.1.5 Zoetis Recent Developments/Updates
  • 6.2 Boehringer Ingelheim
  • 6.2.1 Boehringer Ingelheim Corporation Information
  • 6.2.2 Boehringer Ingelheim Description and Business Overview
  • 6.2.3 Boehringer Ingelheim Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 Boehringer Ingelheim Antiparasitic Drugs for Pets Product Portfolio
  • 6.2.5 Boehringer Ingelheim Recent Developments/Updates
  • 6.3 Merck
  • 6.3.1 Merck Corporation Information
  • 6.3.2 Merck Description and Business Overview
  • 6.3.3 Merck Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 Merck Antiparasitic Drugs for Pets Product Portfolio
  • 6.3.5 Merck Recent Developments/Updates
  • 6.4 Elanco
  • 6.4.1 Elanco Corporation Information
  • 6.4.2 Elanco Description and Business Overview
  • 6.4.3 Elanco Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Elanco Antiparasitic Drugs for Pets Product Portfolio
  • 6.4.5 Elanco Recent Developments/Updates
  • 6.5 Virbac
  • 6.5.1 Virbac Corporation Information
  • 6.5.2 Virbac Description and Business Overview
  • 6.5.3 Virbac Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 Virbac Antiparasitic Drugs for Pets Product Portfolio
  • 6.5.5 Virbac Recent Developments/Updates
  • 6.6 Ceva
  • 6.6.1 Ceva Corporation Information
  • 6.6.2 Ceva Description and Business Overview
  • 6.6.3 Ceva Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 Ceva Antiparasitic Drugs for Pets Product Portfolio
  • 6.6.5 Ceva Recent Developments/Updates
  • 6.7 Vetoquinol
  • 6.6.1 Vetoquinol Corporation Information
  • 6.6.2 Vetoquinol Description and Business Overview
  • 6.6.3 Vetoquinol Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Vetoquinol Antiparasitic Drugs for Pets Product Portfolio
  • 6.7.5 Vetoquinol Recent Developments/Updates
  • 6.8 Ouro Fino Saude
  • 6.8.1 Ouro Fino Saude Corporation Information
  • 6.8.2 Ouro Fino Saude Description and Business Overview
  • 6.8.3 Ouro Fino Saude Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 Ouro Fino Saude Antiparasitic Drugs for Pets Product Portfolio
  • 6.8.5 Ouro Fino Saude Recent Developments/Updates
  • 6.9 JINDUN
  • 6.9.1 JINDUN Corporation Information
  • 6.9.2 JINDUN Description and Business Overview
  • 6.9.3 JINDUN Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 JINDUN Antiparasitic Drugs for Pets Product Portfolio
  • 6.9.5 JINDUN Recent Developments/Updates
  • 6.10 Zhongbolvya
  • 6.10.1 Zhongbolvya Corporation Information
  • 6.10.2 Zhongbolvya Description and Business Overview
  • 6.10.3 Zhongbolvya Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.10.4 Zhongbolvya Antiparasitic Drugs for Pets Product Portfolio
  • 6.10.5 Zhongbolvya Recent Developments/Updates
  • 6.11 CAHIC
  • 6.11.1 CAHIC Corporation Information
  • 6.11.2 CAHIC Antiparasitic Drugs for Pets Description and Business Overview
  • 6.11.3 CAHIC Antiparasitic Drugs for Pets Sales, Revenue and Gross Margin (2017-2022)
  • 6.11.4 CAHIC Antiparasitic Drugs for Pets Product Portfolio
  • 6.11.5 CAHIC Recent Developments/Updates
  • 7 Antiparasitic Drugs for Pets Manufacturing Cost Analysis

    • 7.1 Antiparasitic Drugs for Pets Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Antiparasitic Drugs for Pets
  • 7.4 Antiparasitic Drugs for Pets Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Antiparasitic Drugs for Pets Distributors List
    • 8.3 Antiparasitic Drugs for Pets Customers

    9 Antiparasitic Drugs for Pets Market Dynamics

    • 9.1 Antiparasitic Drugs for Pets Industry Trends
    • 9.2 Antiparasitic Drugs for Pets Market Drivers
    • 9.3 Antiparasitic Drugs for Pets Market Challenges
    • 9.4 Antiparasitic Drugs for Pets Market Restraints

    10 Global Market Forecast

    • 10.1 Antiparasitic Drugs for Pets Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Antiparasitic Drugs for Pets by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Antiparasitic Drugs for Pets by Type (2023-2028)
  • 10.2 Antiparasitic Drugs for Pets Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Antiparasitic Drugs for Pets by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Antiparasitic Drugs for Pets by Application (2023-2028)
  • 10.3 Antiparasitic Drugs for Pets Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Antiparasitic Drugs for Pets by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Antiparasitic Drugs for Pets by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Summary:
      Get latest Market Research Reports on Antiparasitic Drugs for Pets. Industry analysis & Market Report on Antiparasitic Drugs for Pets is a syndicated market report, published as Global Antiparasitic Drugs for Pets Market Research Report 2022. It is complete Research Study and Industry Analysis of Antiparasitic Drugs for Pets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,366.40
      4,732.80
      2,749.20
      5,498.40
      391,993.00
      783,986.00
      226,867.00
      453,734.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report